Desferrithiocin analogue based hexacoordinate iron(III) chelators

Journal of Medicinal Chemistry

Volumn 46, Issue 1, 2003, Pages 16-24

  Bergeron, Raymond J ^a   Huang, Guangfei ^a   Weimar, William R ^a   Smith, Richard E ^a   Wiegand, Jan ^a   McManis, James S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERRIFERRITHIOCIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON CHELATING AGENT; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL BINDING; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; FENTON REACTION; MALE; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; OXIDATION; RAT; SPECIES DIFFERENCE; STOICHIOMETRY;

ANIMALS; ASCORBIC ACID; BILE; CEBUS; DIHYDROPYRIDINES; FECES; FREE RADICAL SCAVENGERS; IRON; IRON CHELATING AGENTS; LIGANDS; OXIDATION-REDUCTION; RESORCINOLS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 0037413555     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020184n     Document Type: Article

References (56)

1. Olivieri, N. F.; Brittenham, G. M. Iron-chelating therapy and the treatment of thalassemia. Blood 1997, 89, 739-761.
2. Wonke, B. Clinical management of β-thalassemia major. Semin. Hematol. 2001, 38, 350-359.
3. Hershko, C.; Cabantchik, Z. I. Control of malaria by drug-mediated iron deprivation. Isr. J. Med. Sci. 1994, 30, 840-845.
4. Mabeza, G. F.; Biemba, G.; Gordeuk, V. R. Clinical studies of iron chelators in malaria. Acta Haematol. 1996, 95, 78-86.
5. Hershko, C. Control of disease by selective iron depletion: A novel therapeutic strategy utilizing iron chelators. Bailliere's Clin. Haematol. 1994, 7, 965-1000.
6. Bel, A.; Martinod, E.; Menasche, P. Cardioprotective effect of desferrioxamine. Acta Haematol. 1996, 95, 63-65.
7. Raymond, K. N.; Carrano, C. J. Coordination chemistry and microbial iron transport. Acc. Chem. Res. 1979, 12, 183-190.
8. Bergeron, R. J. Iron: A controlling nutrient in proliferative processes. Trends Biochem. Sci. 1986, 11, 133-136.
9. Theil, E. C.; Huynh, B. H. Ferritin mineralization: Ferroxidation and beyond. J. Inorg. Biochem. 1997, 67, 30.
10. Ponka, P.; Beaumont, C.; Richardson, D. R. Function and regulation of transferrin and ferritin. Semin. Hematol. 1998, 35, 35-54.
11. Finch, C. A.; Deubelbeiss, K.; Cook, J. D.; Eschbach, J. W.; Harker, L. A.; Funk, D. D.; Marsaglia, G.; Hillman, R. S.; Slichter, S.; Adamson, J. W.; Ganzoni, A.; Giblett, E. R. Ferro-kinetics in man. Medicine (Baltimore) 1970, 49, 17-53.
12. Finch, C. A.; Huebers, H. A. Perspectives in iron metabolism. N. Engl. J. Med. 1982, 306, 1520-1528.
13. Finch, C. A.; Huebers, H. A. Iron metabolism. Clin. Physiol. Biochem. 1986, 4, 5-10.
14. Hallberg, L. Bioavailability of dietary iron in man. Annu. Rev. Nutr. 1981, 1, 123-147.
15. Conrad, M. E.; Umbreit, J. N.; Moore, E. G. Iron absorption and transport. Am. J. Med. Sci. 1999, 318, 213-229.
16. O'Connell, M. J.; Ward, R. J.; Baum, H.; Peters, T. J. The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes. Biochem. J. 1985, 229, 135-139.
17. Seligman, P. A.; Klausner, R. D.; Huebers, H. A. Molecular mechanisms of iron metabolism. In The Molecular Basis of Blood Diseases; Stamatoyannopoulos, G., Nienhuis, A. W., Leder, P., Majeris, P. W., Eds.; W. B. Saunders: Philadelphia, PA, 1987; p 219.
18. Thomas, C. E.; Morehouse, L. A.; Aust, S. D. Ferritin and superoxide-dependent lipid peroxidation. J. Biol. Chem. 1985, 260, 3275-3280.
19. Bickel, H.; Hall, G. E.; Keller-Schierlein, W.; Prelog, V.; Vischer, E.; Wettstein, A. Metabolic products of actinomycetes. XXVII. Constitutional formula of ferrioxamine B. Helv. Chim. Acta 1960, 43, 2129-2138.
20. Porter, J. B. Deferoxamine pharmacokinetics. Semin. Hematol. 2001, 38, 63-68.
21. Lee, P.; Mohammed, N.; Marshall, L.; Abeysinghe, R. D.; Hider, R. C.; Porter, J. B.; Singh, S. Intravenous infusion pharmaco-kinetics of desferrioxamine in thalassaemic patients. Drug Metab. Dispos. 1993, 21, 640-644.
22. Pippard, M. J.; Callender, S. T.; Finch, C. A. Ferrioxamine excretion in iron-loaded man. Blood 1982, 60, 288-294.
23. Pippard, M. J. Desferrioxamine-induced iron excretion in humans. Bailliere's Clin. Haematol. 1989, 2, 323-343.
24. Babbs, C. F. Oxygen radicals in ulcerative colitis. Free Radical Biol. Med. 1992, 13, 169-181.
25. Halliwell, B. Free radicals and antioxidants: A personal view. Nutr. Rev. 1994, 52, 253-265.
26. Hazen, S. L.; d'Avignon, A.; Anderson, M. M.; Hsu, F. F.; Heinecke, J. W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize α-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway. J. Biol. Chem. 1998, 273, 4997-5005.
27. Dean, R. T.; Nicholson, P. The action of nine chelators on iron-dependent radical damage. Free Radical Res. 1994, 20, 83-101.
28. Graf, E.; Mahoney, J. R.; Bryant, R. G.; Eaton, J. W. Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J. Biol. Chem. 1984, 259, 3620-3624.
29. Grisham, M. B. Effect of 5-aminosalicylic acid on ferrous sulfate-mediated damage to deoxyribose. Biochem. Pharmacol. 1990, 39, 2060-2063.
30. Grisham, M. B.; Ware, K.; Marshall, S.; Yamada, T.; Sandhu, I. Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects. Dig. Dis. Sci. 1992, 37, 1383-1389.
31. Cragg, L.; Hebbel, R. P.; Miller, W.; Solovey, A.; Selby, S.; Enright, H. The iron chelator L1 potentiates oxidative dna damage in iron-loaded liver cells. Blood 1998, 92, 632-638.
32. Hiraishi, H.; Terano, A.; Ota, S.; Mutoh, H.; Razandi, M.; Sugimoto, T.; Ivey, K. J. Role for iron in reactive oxygen species-mediated cytotoxicity to cultured rat gastric mucosal cells. Am. J. Physiol. 1991, 260, G556-G563.
33. Denicola, A.; Souza, J. M.; Gatti, R. M.; Augusto, O.; Radi, R. Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: Role of the hydroxamic groups. Free Radical Biol. Med. 1995, 19, 11-19.
34. Samuni, A. M.; Afeworki, M.; Stein, W.; Yordanov, A. T.; DeGraff, W.; Krishna, M. C.; Mitchell, J. B.; Brechbiel, M. W. Multifunctional antioxidant activity of HBED iron chelator. Free Radical Biol. Med. 2001, 30, 170-177.
35. Bergeron, R. J.; Wiegand, J.; Weimar, W. R.; Vinson, J. R. T.; Bussenius, J.; Yao, G. W.; McManis, J. S. Desazadesmethyldes-ferrithiocin analogues as orally effective iron chelators. J. Med. Chem. 1999, 42, 95-108.
36. Bergeron, R. J.; Wiegand, J.; McManis, J. S.; McCosar, B. H.; Weimar, W. R.; Brittenham, G. M.; Smith, R. E. Effects of C-4 stereochemistry and C-4′ hydroxylation on the iron clearing efficiency and toxicity of desferrithiocin analogues. J. Med. Chem. 1999, 42, 2432-2440.
37. Bergeron, R. J.; Weimar, W. R.; Wiegand, J. Pharmacokinetics of orally administered desferrithiocin analogs in cebus apella primates. Drug Metab. Dispos. 1999, 27, 1496-1498.
38. Bergeron, R. J.; Wiegand, J.; McManis, J. S.; Perumal, P. T. Synthesis and biological evaluation of hydroxamate-based iron chelators. J. Med. Chem. 1991, 34, 3182-3187.
39. Hahn, F. E.; McMurry, T. J.; Hugi, A.; Raymond, K. N. Coordination chemistry of microbial iron transport. 42. Structural and spectroscopic characterization of diastereomeric Cr(III) and Co(III) complexes of desferriferrithiocin. J. Am. Chem. Soc. 1990, 112, 1854-1860.
40. Amakasu, T.; Sato, K. Coumarins. II. The acid-catalyzed reaction of phenols with simple α,β-unsaturated acids. J. Am. Chem. Soc. 1966, 31, 1433-1436.
41. Mendelson, W. L.; Hayden, S. Preparation of 2,4-dihydroxy-benzaldehyde by the Vilsmeier-Haack reaction. Synth. Commun. 1996, 26, 603-610.
42. Wang, E.-C.; Lin, G.-J. A new one pot method for the conversion of aldehydes into nitriles using hydroxylamine and phthalic anhydride. Tetrahedron Lett. 1998, 39, 4047-4050.
43. DiLabio, G. A.; Wright, J. S. Hemiketal formation of dehydro-ascorbic acid drives ascorbyl radical anion disproportionation. Free Radical Biol. Med. 2000, 29, 480-485.
44. Anderegg, G.; L'Eplattenier, F.; Schwarzenbach, G. Hydroxamate complexes. III. Iron(III) exchange between sideramines and complexones. A discussion of the formation constants of the hydroxamate complexes. Helv. Chim. Acta 1963, 46, 1409-1422.
45. Anderegg, G.; L'Eplattenier, F.; Schwarzenbach, G. Hydroxamate complexes. II. Application of the pH method. Helv. Chim. Acta 1963, 46, 1400-1408.
46. Martell, A. E.; Smith, R. Other Organic Ligands; Plenum: New York, 1976.
47. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol. Med. 1999, 26, 1231-1237.
48. Bergeron, R. J.; Wiegand, J.; Dionis, J. B.; Egli-Karmakka, M.; Frei, J.; Huxley-Tencer, A.; Peter, H. H. Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators. J. Med. Chem. 1991, 34, 2072-2078.
49. Bergeron, R. J.; Streiff, R. R.; Wiegand, J.; Luchetta, G.; Creary, E. A.; Peter, H. H. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine. Blood 1992, 79, 1882-1890.
50. Bergeron, R. J.; Wiegand, J.; Brittenham, G. M. HBED: The continuing development of a potential alternative to deferoxamine for iron-chelating therapy. Blood 1999, 93, 370-375.
51. Bergeron, R. J.; Streiff, R. R.; Creary, E. A.; Daniels, R. D., Jr.; King, W.; Luchetta, G.; Wiegand, J.; Moerker, T.; Peter, H. H. A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a cebus monkey model. Blood 1993, 81, 2166-2173.
52. Gomori, G. Preparation of buffers for use in enzyme studies. Methods Enzymol. 1955, 1, 138-146.
53. Bergeron, R. J.; Wiegand, J.; Brittenham, G. M. HBED: A potential alternative to deferoxamine for iron-chelating therapy. Blood 1998, 91, 1446-1452.
54. Bergeron, R. J.; Wiegand, J.; Wollenweber, M.; McManis, J. S.; Algee, S. E.; Ratliff-Thompson, K. Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators. J. Med. Chem. 1996, 39, 1575-1581.
55. Wood, J. K.; Milner, P. F.; Pathak, U. N. The metabolism of iron-dextran given as a total-dose infusion to iron deficient jamaican subjects. Br. J. Haematol. 1968, 14, 119-129.
56. Bergeron, R. J.; Streiff, R. R.; Wiegand, J.; Vinson, J. R. T.; Luchetta, G.; Evans, K. M.; Peter, H.; Jenny, H.-B. A comparative evaluation of iron clearance models. Ann. N.Y. Acad. Sci. 1990, 612, 378-393.